Arcadia Biosciences Ownership 2024 | Who Owns Arcadia Biosciences Now?

Overview Forecast RevenueFinancials Chart Transcripts

Institutional Ownership

394.82%

Insider Ownership

2.73%

Retail Ownership

-297.56%

Institutional Holders

28.00

Arcadia Biosciences Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SABBY MANAGEMENT, LLC	100.00%	0.34%	52,874	52,874	100.00%	394,969,000	Mar 31, 2023
ARMISTICE CAPITAL, LLC	100.00%	0.01%	82,500	82,500	100.00%	616,275,000	Mar 31, 2023
STATE STREET CORP	81.05%	-	12,146	12,146	100.00%	90,731,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	68.06%	-	10,199	10,199	100.00%	76,000	Mar 31, 2023
UBS GROUP AG	21.41%	-	3,209	3,209	100.00%	23,971,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	3.86%	-	579	579	100.00%	4,325,000	Mar 31, 2023
MORGAN STANLEY	1.45%	-	218	218	100.00%	1,629,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.69%	-	104	104	100.00%	777,000	Mar 31, 2023
BLACKROCK INC.	0.25%	-	38	38	100.00%	284,000	Mar 31, 2023
FMR LLC	0.05%	-	8	8	100.00%	60,000	Mar 31, 2023
US BANCORP \DE\	0.03%	-	5	5	100.00%	37,000	Mar 31, 2023
HARBOUR INVESTMENTS, INC.	0.01%	-	1	1	100.00%	7,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-7,061	-100.00%	-	Mar 31, 2023
ERGOTELES LLC	-	-	-	-1,164	-100.00%	-	Mar 31, 2023
JANE STREET GROUP, LLC	-	-	-	-1,365	-100.00%	-	Mar 31, 2023
VIRTU FINANCIAL LLC	-	-	-	-329	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-354	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-323	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-579	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-4,536	-100.00%	-	Mar 31, 2023

Arcadia Biosciences's largest institutional shareholder is SABBY MANAGEMENT, LLC, holding 100.00% of the company's total share outstanding, currently valued at $394.97M. The top 10 institutional shareholders own together 376.85% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SABBY MANAGEMENT, LLC	100.00%	0.34%	52,874	52,874	100.00%	394,969,000	Mar 31, 2023
ARMISTICE CAPITAL, LLC	100.00%	0.01%	82,500	82,500	100.00%	616,275,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	68.06%	-	10,199	10,199	100.00%	76,000	Mar 31, 2023
UBS GROUP AG	21.41%	-	3,209	3,209	100.00%	23,971,000	Mar 31, 2023
STATE STREET CORP	81.05%	-	12,146	12,146	100.00%	90,731,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.69%	-	104	104	100.00%	777,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	3.86%	-	579	579	100.00%	4,325,000	Mar 31, 2023
HARBOUR INVESTMENTS, INC.	0.01%	-	1	1	100.00%	7,000	Mar 31, 2023
MORGAN STANLEY	1.45%	-	218	218	100.00%	1,629,000	Mar 31, 2023
US BANCORP \DE\	0.03%	-	5	5	100.00%	37,000	Mar 31, 2023
BLACKROCK INC.	0.25%	-	38	38	100.00%	284,000	Mar 31, 2023
FMR LLC	0.05%	-	8	8	100.00%	60,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-7,061	-100.00%	-	Mar 31, 2023
ERGOTELES LLC	-	-	-	-1,164	-100.00%	-	Mar 31, 2023
JANE STREET GROUP, LLC	-	-	-	-1,365	-100.00%	-	Mar 31, 2023
VIRTU FINANCIAL LLC	-	-	-	-329	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-354	-100.00%	-	Mar 31, 2023
LPL FINANCIAL LLC	-	-	-	-1,025	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-579	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-13	-100.00%	-	Mar 31, 2023

The largest Arcadia Biosciences shareholder by % of total assets is SABBY MANAGEMENT, LLC. The company owns 52.87K shares of Arcadia Biosciences (RKDA), representing 0.34% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ARMISTICE CAPITAL, LLC	100.00%	0.01%	82,500	82,500	100.00%	616,275,000	Mar 31, 2023
SABBY MANAGEMENT, LLC	100.00%	0.34%	52,874	52,874	100.00%	394,969,000	Mar 31, 2023
STATE STREET CORP	81.05%	-	12,146	12,146	100.00%	90,731,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	68.06%	-	10,199	10,199	100.00%	76,000	Mar 31, 2023
UBS GROUP AG	21.41%	-	3,209	3,209	100.00%	23,971,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	3.86%	-	579	579	100.00%	4,325,000	Mar 31, 2023
MORGAN STANLEY	1.45%	-	218	218	100.00%	1,629,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.69%	-	104	104	100.00%	777,000	Mar 31, 2023
BLACKROCK INC.	0.25%	-	38	38	100.00%	284,000	Mar 31, 2023
FMR LLC	0.05%	-	8	8	100.00%	60,000	Mar 31, 2023
US BANCORP \DE\	0.03%	-	5	5	100.00%	37,000	Mar 31, 2023
HARBOUR INVESTMENTS, INC.	0.01%	-	1	1	100.00%	7,000	Mar 31, 2023
HARBOUR INVESTMENTS, INC.	-	-	-	-1	-100.00%	-	Mar 31, 2023
PNC FINANCIAL SERVICES GROUP, INC.	-	-	-	-5	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-13	-100.00%	-	Mar 31, 2023
GROUP ONE TRADING, L.P.	-	-	-	-158	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-213	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-269	-100.00%	-	Mar 31, 2023
GOLDMAN SACHS GROUP INC	-	-	-	-276	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-323	-100.00%	-	Mar 31, 2023

As of Mar 31 2023, Arcadia Biosciences's largest institutional buyer is ARMISTICE CAPITAL, LLC. The company purchased 82.50K stocks of RKDA, valued at $616.27M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ARMISTICE CAPITAL, LLC	-	-	-	-13,438	-100.00%	-	Mar 31, 2023
VANGUARD GROUP INC	-	-	-	-7,683	-100.00%	-	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-7,061	-100.00%	-	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-4,636	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-4,536	-100.00%	-	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-4,437	-100.00%	-	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-3,613	-100.00%	-	Mar 31, 2023
STATE STREET CORP	-	-	-	-2,545	-100.00%	-	Mar 31, 2023
HRT FINANCIAL LP	-	-	-	-2,080	-100.00%	-	Mar 31, 2023
HIGHTOWER ADVISORS, LLC	-	-	-	-1,598	-100.00%	-	Mar 31, 2023
JANE STREET GROUP, LLC	-	-	-	-1,365	-100.00%	-	Mar 31, 2023
ERGOTELES LLC	-	-	-	-1,164	-100.00%	-	Mar 31, 2023
LPL FINANCIAL LLC	-	-	-	-1,025	-100.00%	-	Mar 31, 2023
BLACKROCK INC.	-	-	-	-756	-100.00%	-	Mar 31, 2023
NORTHERN TRUST CORP	-	-	-	-724	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-579	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-354	-100.00%	-	Mar 31, 2023
VIRTU FINANCIAL LLC	-	-	-	-329	-100.00%	-	Mar 31, 2023
CALTON & ASSOCIATES, INC.	-	-	-	-325	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-323	-100.00%	-	Mar 31, 2023

As of Mar 31 2023, Arcadia Biosciences's biggest institutional seller is ARMISTICE CAPITAL, LLC. The company sold -13.44K shares of RKDA, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ARMISTICE CAPITAL, LLC	100.00%	0.01%	82,500	82,500	100.00%	616,275,000	Mar 31, 2023
SABBY MANAGEMENT, LLC	100.00%	0.34%	52,874	52,874	100.00%	394,969,000	Mar 31, 2023
STATE STREET CORP	81.05%	-	12,146	12,146	100.00%	90,731,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	68.06%	-	10,199	10,199	100.00%	76,000	Mar 31, 2023
UBS GROUP AG	21.41%	-	3,209	3,209	100.00%	23,971,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	3.86%	-	579	579	100.00%	4,325,000	Mar 31, 2023
MORGAN STANLEY	1.45%	-	218	218	100.00%	1,629,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.69%	-	104	104	100.00%	777,000	Mar 31, 2023
BLACKROCK INC.	0.25%	-	38	38	100.00%	284,000	Mar 31, 2023
FMR LLC	0.05%	-	8	8	100.00%	60,000	Mar 31, 2023
US BANCORP \DE\	0.03%	-	5	5	100.00%	37,000	Mar 31, 2023
HARBOUR INVESTMENTS, INC.	0.01%	-	1	1	100.00%	7,000	Mar 31, 2023

Arcadia Biosciences's largest new institutional shareholder by number of shares is ARMISTICE CAPITAL, LLC, purchased 82.50K shares, valued at $616.27M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ARMISTICE CAPITAL, LLC	-	-	-	-13,438	-100.00%	-	Mar 31, 2023
VANGUARD GROUP INC	-	-	-	-7,683	-100.00%	-	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	-	-	-	-7,061	-100.00%	-	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-4,636	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-4,536	-100.00%	-	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-4,437	-100.00%	-	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-3,613	-100.00%	-	Mar 31, 2023
STATE STREET CORP	-	-	-	-2,545	-100.00%	-	Mar 31, 2023
HRT FINANCIAL LP	-	-	-	-2,080	-100.00%	-	Mar 31, 2023
HIGHTOWER ADVISORS, LLC	-	-	-	-1,598	-100.00%	-	Mar 31, 2023
JANE STREET GROUP, LLC	-	-	-	-1,365	-100.00%	-	Mar 31, 2023
ERGOTELES LLC	-	-	-	-1,164	-100.00%	-	Mar 31, 2023
LPL FINANCIAL LLC	-	-	-	-1,025	-100.00%	-	Mar 31, 2023
BLACKROCK INC.	-	-	-	-756	-100.00%	-	Mar 31, 2023
NORTHERN TRUST CORP	-	-	-	-724	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-579	-100.00%	-	Mar 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-354	-100.00%	-	Mar 31, 2023
VIRTU FINANCIAL LLC	-	-	-	-329	-100.00%	-	Mar 31, 2023
CALTON & ASSOCIATES, INC.	-	-	-	-325	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-323	-100.00%	-	Mar 31, 2023
GOLDMAN SACHS GROUP INC	-	-	-	-276	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-269	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-213	-100.00%	-	Mar 31, 2023
GROUP ONE TRADING, L.P.	-	-	-	-158	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-13	-100.00%	-	Mar 31, 2023
PNC FINANCIAL SERVICES GROUP, INC.	-	-	-	-5	-100.00%	-	Mar 31, 2023
HARBOUR INVESTMENTS, INC.	-	-	-	-1	-100.00%	-	Mar 31, 2023

Arcadia Biosciences's largest sold out institutional shareholder by shares sold is ARMISTICE CAPITAL, LLC, sold -13.44K shares, valued at -, as of undefined.

Arcadia Biosciences Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
Vericimetry Funds	0.08%	7,170	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	164,306	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	300,540	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	7,046	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	14,038	-14,038	-50.00%	Mar 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	28,886	-	-	Jan 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	2,656	-	-	Jan 31, 2024
Dimensional ETF Trust	0.00%	4,475	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	4,445	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	28,728	-	-	Mar 31, 2024

Arcadia Biosciences's largest mutual fund holder by % of total assets is "Vericimetry Funds", owning 7.17K shares, compromising 0.08% of its total assets.

Arcadia Biosciences Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Dec, 22	28	27.27%
30 Sep, 22	22	15.79%
30 Jun, 22	19	-24.00%
31 Mar, 22	25	-7.41%
31 Dec, 21	27	17.39%
30 Sep, 21	23	-30.30%
30 Jun, 21	33	13.79%
31 Mar, 21	29	52.63%
31 Dec, 20	19	5.56%
30 Sep, 20	18	28.57%
30 Jun, 20	14	27.27%
31 Mar, 20	11	-31.25%
31 Dec, 19	16	-11.11%
30 Sep, 19	18	38.46%
30 Jun, 19	13	30.00%
31 Mar, 19	10	-
31 Dec, 18	10	-9.09%
30 Sep, 18	11	-
30 Jun, 18	11	-
31 Mar, 18	11	1000.00%
31 Dec, 17	1	-

As of 31 Dec 22, 28 institutions are holding Arcadia Biosciences's shares, representing an increase of 27.27% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Dec, 22	2,366,535	-27.91%
30 Sep, 22	3,282,701	93.73%
30 Jun, 22	1,694,503	-11.72%
31 Mar, 22	1,919,375	-17.97%
31 Dec, 21	2,339,761	-26.00%
30 Sep, 21	3,161,836	26.82%
30 Jun, 21	2,493,135	116.61%
31 Mar, 21	1,150,998	3.12%
31 Dec, 20	1,116,155	28.41%
30 Sep, 20	869,212	66.14%
30 Jun, 20	523,171	22.42%
31 Mar, 20	427,349	-14.24%
31 Dec, 19	498,337	-26.02%
30 Sep, 19	673,643	95.27%
30 Jun, 19	344,982	79.10%
31 Mar, 19	192,623	-31.71%
31 Dec, 18	282,070	-35.56%
30 Sep, 18	437,739	64.07%
30 Jun, 18	266,807	-32.53%
31 Mar, 18	395,430	1407.66%
31 Dec, 17	26,228	-

Arcadia Biosciences (RKDA) has 2.37M shares outstanding as of 31 Dec 22, down -27.91% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Dec, 22	394.82%	0.13%
30 Sep, 22	549.60%	0.59%
30 Jun, 22	305.52%	0.26%
31 Mar, 22	346.04%	0.18%
31 Dec, 21	439.79%	0.13%
30 Sep, 21	581.49%	0.28%
30 Jun, 21	458.60%	0.78%
31 Mar, 21	242.70%	0.12%
31 Dec, 20	448.30%	0.43%
30 Sep, 20	324.34%	0.64%
30 Jun, 20	224.36%	0.57%
31 Mar, 20	197.59%	0.20%
31 Dec, 19	313.27%	0.21%
30 Sep, 19	388.12%	0.52%
30 Jun, 19	272.99%	1.05%
31 Mar, 19	161.31%	0.18%
31 Dec, 18	299.56%	0.22%
30 Sep, 18	366.71%	0.35%
30 Jun, 18	322.66%	0.06%
31 Mar, 18	723.52%	30.56%
31 Dec, 17	48.66%	-

As of 31 Dec 22, Arcadia Biosciences is held by 394.82% institutional shareholders, representing a 0.13% growth compared to 30 Sep 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Dec, 22	13	8.33%
30 Sep, 22	12	50.00%
30 Jun, 22	8	-33.33%
31 Mar, 22	12	-7.69%
31 Dec, 21	13	44.44%
30 Sep, 21	9	-52.63%
30 Jun, 21	19	-5.00%
31 Mar, 21	20	122.22%
31 Dec, 20	9	-18.18%
30 Sep, 20	11	37.50%
30 Jun, 20	8	-
31 Mar, 20	8	-20.00%
31 Dec, 19	10	-16.67%
30 Sep, 19	12	33.33%
30 Jun, 19	9	80.00%
31 Mar, 19	5	66.67%
31 Dec, 18	3	-57.14%
30 Sep, 18	7	-12.50%
30 Jun, 18	8	-27.27%
31 Mar, 18	11	1000.00%
31 Dec, 17	1	-

13 institutional shareholders have increased their position in RKDA stock as of 31 Dec 22 compared to 12 in the previous quarter (a 8.33% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Dec, 22	10	66.67%
30 Sep, 22	6	-14.29%
30 Jun, 22	7	16.67%
31 Mar, 22	6	-
31 Dec, 21	6	20.00%
30 Sep, 21	5	-28.57%
30 Jun, 21	7	250.00%
31 Mar, 21	2	-50.00%
31 Dec, 20	4	100.00%
30 Sep, 20	2	-
30 Jun, 20	2	100.00%
31 Mar, 20	1	-66.67%
31 Dec, 19	3	200.00%
30 Sep, 19	1	-
30 Jun, 19	-	-100.00%
31 Mar, 19	1	-50.00%
31 Dec, 18	2	100.00%
30 Sep, 18	1	-
30 Jun, 18	1	-
31 Mar, 18	-	-
31 Dec, 17	-	-

10 institutional shareholders have reduced their position in RKDA stock as of 31 Dec 22 compared to 6 in the previous quarter (a 66.67% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Dec, 22	28	27.27%	2,366,535	-27.91%	394.82%	0.13%	13	8.33%	10	66.67%
30 Sep, 22	22	15.79%	3,282,701	93.73%	549.60%	0.59%	12	50.00%	6	-14.29%
30 Jun, 22	19	-24.00%	1,694,503	-11.72%	305.52%	0.26%	8	-33.33%	7	16.67%
31 Mar, 22	25	-7.41%	1,919,375	-17.97%	346.04%	0.18%	12	-7.69%	6	-
31 Dec, 21	27	17.39%	2,339,761	-26.00%	439.79%	0.13%	13	44.44%	6	20.00%
30 Sep, 21	23	-30.30%	3,161,836	26.82%	581.49%	0.28%	9	-52.63%	5	-28.57%
30 Jun, 21	33	13.79%	2,493,135	116.61%	458.60%	0.78%	19	-5.00%	7	250.00%
31 Mar, 21	29	52.63%	1,150,998	3.12%	242.70%	0.12%	20	122.22%	2	-50.00%
31 Dec, 20	19	5.56%	1,116,155	28.41%	448.30%	0.43%	9	-18.18%	4	100.00%
30 Sep, 20	18	28.57%	869,212	66.14%	324.34%	0.64%	11	37.50%	2	-
30 Jun, 20	14	27.27%	523,171	22.42%	224.36%	0.57%	8	-	2	100.00%
31 Mar, 20	11	-31.25%	427,349	-14.24%	197.59%	0.20%	8	-20.00%	1	-66.67%
31 Dec, 19	16	-11.11%	498,337	-26.02%	313.27%	0.21%	10	-16.67%	3	200.00%
30 Sep, 19	18	38.46%	673,643	95.27%	388.12%	0.52%	12	33.33%	1	-
30 Jun, 19	13	30.00%	344,982	79.10%	272.99%	1.05%	9	80.00%	-	-100.00%
31 Mar, 19	10	-	192,623	-31.71%	161.31%	0.18%	5	66.67%	1	-50.00%
31 Dec, 18	10	-9.09%	282,070	-35.56%	299.56%	0.22%	3	-57.14%	2	100.00%
30 Sep, 18	11	-	437,739	64.07%	366.71%	0.35%	7	-12.50%	1	-
30 Jun, 18	11	-	266,807	-32.53%	322.66%	0.06%	8	-27.27%	1	-
31 Mar, 18	11	1000.00%	395,430	1407.66%	723.52%	30.56%	11	1000.00%	-	-
31 Dec, 17	1	-	26,228	-	48.66%	-	1	-	-	-

Arcadia Biosciences Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Feb 05, 2024	Schaefer Thomas J.	officer	Chief Financial Officer	P-Purchase	Buy	700	$2.06	$1.44K	1,419
Aug 07, 2023	Schaefer Thomas J.	officer	Chief Financial Officer	P-Purchase	Buy	649	$3.67	$2.38K	719
May 30, 2023	Jacot Stanley Jr	officer	Chief Executive Officer	P-Purchase	Buy	5,000	$4.31	$21.55K	5,000
Feb 02, 2023	Schaefer Thomas J.	officer	Chief Financial Officer	P-Purchase	Buy	700	$0.23	$161.00	2,800

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Feb 05, 2024	Schaefer Thomas J.	officer	Chief Financial Officer	P-Purchase	Buy	700	$2.06	$1.44K	1,419
Aug 07, 2023	Schaefer Thomas J.	officer	Chief Financial Officer	P-Purchase	Buy	649	$3.67	$2.38K	719
May 30, 2023	Jacot Stanley Jr	officer	Chief Executive Officer	P-Purchase	Buy	5,000	$4.31	$21.55K	5,000
Feb 02, 2023	Schaefer Thomas J.	officer	Chief Financial Officer	P-Purchase	Buy	700	$0.23	$161.00	2,800

Insider Sells

Date	Name	Relation	Role	Buy/Sell	Shares	Price	Value	Shares Held
Jul 18, 2024	Kawakami Mark	officer	Chief Financial Officer	Sell	-	-	-	1,281
Jul 18, 2024	Kawakami Mark	officer	Chief Financial Officer	Sell	300	$90.80	$27.24K	-
Jul 18, 2024	Kawakami Mark	officer	Chief Financial Officer	Sell	300	$50.80	$15.24K	-
Jul 18, 2024	Kawakami Mark	officer	Chief Financial Officer	Sell	137	$37.74	$5.17K	-
Jul 18, 2024	Kawakami Mark	officer	Chief Financial Officer	Sell	250	$10.80	$2.70K	-
Jul 18, 2024	Kawakami Mark	officer	Chief Financial Officer	Sell	500	$4.68	$2.34K	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 18, 2024	Kawakami Mark	officer	Chief Financial Officer		Sell	-	-	-	1,281
Jul 18, 2024	Kawakami Mark	officer	Chief Financial Officer		Sell	300	$90.80	$27.24K	-
Jul 18, 2024	Kawakami Mark	officer	Chief Financial Officer		Sell	300	$50.80	$15.24K	-
Jul 18, 2024	Kawakami Mark	officer	Chief Financial Officer		Sell	137	$37.74	$5.17K	-
Jul 18, 2024	Kawakami Mark	officer	Chief Financial Officer		Sell	250	$10.80	$2.70K	-
Jul 18, 2024	Kawakami Mark	officer	Chief Financial Officer		Sell	500	$4.68	$2.34K	-
Feb 05, 2024	Schaefer Thomas J.	officer	Chief Financial Officer	P-Purchase	Buy	700	$2.06	$1.44K	1,419
Aug 07, 2023	Schaefer Thomas J.	officer	Chief Financial Officer	P-Purchase	Buy	649	$3.67	$2.38K	719
Jun 16, 2023	Carosella Deborah D	director	-	A-Award	Buy	937	$4.80	$4.50K	2,346
Jun 16, 2023	Yoder Amy	director	-	A-Award	Buy	937	$4.80	$4.50K	2,533
Jun 16, 2023	Bolles Albert D.	director	-	A-Award	Buy	937	$4.80	$4.50K	2,485
Jun 16, 2023	WALLER GREGORY D	director	-	A-Award	Buy	937	$4.80	$4.50K	2,429
Jun 16, 2023	Murray Lilian Shackelford	director	-	A-Award	Buy	937	$4.80	$4.50K	2,378
Jun 16, 2023	Comcowich Kevin	director	-	A-Award	Buy	2,186	$4.80	$10.49K	5,587
May 30, 2023	Jacot Stanley Jr	officer	Chief Executive Officer	P-Purchase	Buy	5,000	$4.31	$21.55K	5,000
Apr 28, 2023	PITLIK LAURA	officer	Chief Marketing Officer	A-Award	Buy	1,500	$7.55	$11.32K	5,300
Apr 28, 2023	Jacot Stanley Jr	officer	Chief Executive Officer	A-Award	Buy	1,500	$7.55	$11.32K	9,402
Apr 28, 2023	Schaefer Thomas J.	officer	Chief Financial Officer	A-Award	Buy	1,500	$7.55	$11.32K	5,475
Feb 02, 2023	Schaefer Thomas J.	officer	Chief Financial Officer	P-Purchase	Buy	700	$0.23	$161.00	2,800
Jan 05, 2023	Schaefer Thomas J.	officer	Chief Financial Officer	A-Award	Buy	50,000	-	-	159,000

The last insider sell of Arcadia Biosciences's stock was made by Kawakami Mark on Jul 18 2024, selling - shares at - per share (valued at -). The last insider buy of RKDA was made by Schaefer Thomas J. on Feb 05 2024, buying 700 shares at $2.06 per share (worth $1.44K).

Arcadia Biosciences Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2023	4	-	-
Q1 2023	2	2	100.00%
Q3 2022	3	-	-
Q2 2022	8	-	-
Q1 2022	1	-	-
Q3 2021	1	-	-
Q2 2021	7	-	-
Q1 2021	4	-	-
Q3 2020	5	-	-
Q2 2020	6	3	200.00%
Q1 2020	6	-	-
Q4 2019	4	-	-
Q3 2019	21	9	233.33%
Q2 2019	9	-	-
Q3 2018	3	-	-
Q2 2018	7	1	700.00%
Q1 2018	5	8	62.50%
Q4 2017	-	1	-
Q3 2017	1	-	-
Q2 2017	9	5	180.00%

4 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Arcadia Biosciences's insiders, as of Q2 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2023	1	-	-
Q1 2023	1	-	-
Q3 2022	1	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q3 2021	-	-	-
Q2 2021	-	-	-
Q1 2021	-	-	-
Q3 2020	3	-	-
Q2 2020	-	-	-
Q1 2020	3	-	-
Q4 2019	4	-	-
Q3 2019	14	-	-
Q2 2019	-	-	-
Q3 2018	-	-	-
Q2 2018	-	-	-
Q1 2018	-	4	-
Q4 2017	-	1	-
Q3 2017	-	-	-
Q2 2017	1	-	-

As of Q2 2023, Insider owners conducted 1 open market buy trades and 0 open market sell trades of Arcadia Biosciences's stocks.

Arcadia Biosciences Peer Ownership

Ticker	Company
YGF	YanGuFang International Group Co., Ltd.
RIBT	RiceBran Technologies
BTOG	Bit Origin Limited
BRID	Bridgford Foods Corporation
SENEA	Seneca Foods Corporation
SMFL	Smart for Life, Inc.
FAMI	Farmmi, Inc.
SNAX	Stryve Foods, Inc.

RKDA Ownership FAQ

Who Owns Arcadia Biosciences?

Arcadia Biosciences is owned by institutional shareholders (394.82%), insiders (2.73%), and public (-297.56%). The largest institutional shareholder of Arcadia Biosciences is SABBY MANAGEMENT, LLC (100.00% of total shares) and the top mutual fund owner is Vericimetry Funds (0.08% of total shares).

Who are the major institutional shareholders of Arcadia Biosciences?

Arcadia Biosciences's major institutional shareholders are SABBY MANAGEMENT, LLC, ARMISTICE CAPITAL, LLC, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, and UBS GROUP AG. The top five shareholders own together 370.53% of the company's share outstanding.

How many Arcadia Biosciences shareholders are there?

As of Dec 2022, there are 28 institutional shareholders of Arcadia Biosciences.

What percentage of Arcadia Biosciences is owned by SABBY MANAGEMENT, LLC?

SABBY MANAGEMENT, LLC owns 52.87K shares of Arcadia Biosciences, representing 100.00% of the company's total shares outstanding, valued at $394.97M (as of Mar 2023).

What percentage of Arcadia Biosciences is owned by ARMISTICE CAPITAL, LLC?

As of Mar 2023, ARMISTICE CAPITAL, LLC holds 82.5K shares of Arcadia Biosciences (RKDA), compromising 100.00% of the company, valued at $616.28M.

What percentage of Arcadia Biosciences is owned by STATE STREET CORP?

STATE STREET CORP is the third largest holder of Arcadia Biosciences. The company owns 12.15K of the company's shares outstanding (worth $90.73M).